A possible Guillain-Barré syndrome/transverse myelitis overlap syndrome after recent COVID-19

© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

Neurological manifestations are common in SARS-CoV-2 infection, including life-threatening acute muscle weakness, due to neuromuscular disorders such as acute transverse myelitis (TM) and Guillain-Barré syndrome (GBS). These syndromes can rarely coexist and present as an overlap syndrome. Here, we report a patient who developed acute symmetrical proximal lower limb weakness 5 days after diagnosis of COVID-19. GBS was diagnosed due to the presence of motor signs, albumin-cytological dissociation in cerebrospinal fluid examination and axonal damage according to nerve condition tests. However, abnormal areas on MRI of the thoracic spine and lack of improvement with intravenous immunoglobulin supported a diagnosis of TM. Therefore, a possible overlap between GBS and TM was established. To our knowledge, this is the third case report of GBS/TM overlap syndrome after COVID-19. The patient's full and rapid recovery with intravenous corticosteroids and plasmapheresis supports our diagnosis.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

BMJ case reports - 15(2022), 2 vom: 09. Feb.

Sprache:

Englisch

Beteiligte Personen:

Alrubaye, Riyadh [VerfasserIn]
Bondugula, Vijayamala [VerfasserIn]
Baleguli, Vidya [VerfasserIn]
Chofor, Rosemary [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Case Reports
Infection (neurology)
Journal Article
Neuroimaging
Neuromuscular disease
Spinal cord

Anmerkungen:

Date Completed 11.02.2022

Date Revised 23.02.2022

published: Electronic

Citation Status MEDLINE

doi:

10.1136/bcr-2021-246967

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM336723644